Similar articles

• Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.

  Seale AC, Toussaint FS, Finn A, Fraser JI. Seale AC, et al. Arch Dis Child. 2011 Sep;96(9):902-3. doi: 10.1136/adc.2010.183806. Epub 2010 Aug 10. Arch Dis Child. 2011. PMID: 20702390 No abstract available.
• Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore.

  Low CY, Kee T, Chan KP, Oon LL, Tan CK, Tee NW, Tan BH. Low CY, et al. Transplantation. 2010 Nov 15;90(9):1016-21. doi: 10.1097/TP.0b013e3181f546cf. Transplantation. 2010. PMID: 20814355
• Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.

  Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, Principi N. Esposito S, et al. J Clin Virol. 2010 May;48(1):62-5. doi: 10.1016/j.jcv.2010.02.019. Epub 2010 Mar 23. J Clin Virol. 2010. PMID: 20335065
• The use of antiviral agents for the management of severe influenza.

  Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
• Influenza 2010-2011: lessons from the 2009 pandemic.

  Ison MG, Lee N. Ison MG, et al. Cleve Clin J Med. 2010 Nov;77(11):812-20. doi: 10.3949/ccjm.77a.10135. Cleve Clin J Med. 2010. PMID: 21048054 Review.